• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Protocol & QC Guide

  2026-05-29

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for high-specificity, affinity-purified detection of rabbit IgG across ELISA, Western blot, and immunohistochemistry workflows. This secondary antibody is not suitable for diagnostic or clinical use and should be reserved for research applications requiring reliable signal amplification with minimal background.

• Alda 1: ALDH2 Activator Workflows for Cardiac & Dermatitis M

  2026-05-29

  Alda 1, a potent ALDH2 activator from APExBIO, enables researchers to precisely modulate aldehyde metabolism in cardiac ischemia and radiation-induced dermatitis models. This guide details experimental workflows, protocol optimizations, and troubleshooting strategies to maximize translational impact in cardioprotection and skin injury research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-05-28

  This study provides a detailed molecular and epidemiological characterization of carbapenemase-encoding genes (CEGs) among carbapenem-resistant Enterobacter cloacae (CREC) isolates from eight hospitals in Guangdong, China. Key findings reveal the predominance and transferability of blaNDM-1 genes, high multidrug resistance rates, and significant implications for infection control and antimicrobial stewardship.

• Anlotinib Hydrochloride: Selective VEGFR2 Inhibition in Tumo

  2026-05-28

  This article reviews the seminal preclinical study that established anlotinib hydrochloride as a potent, highly selective VEGFR2 inhibitor for anti-angiogenic therapy. The findings highlight anlotinib’s superior efficacy and tolerability, underscoring its promise in advancing cancer research targeting tumor vasculature.

• Anlotinib Hydrochloride: Redefining Translational Anti-Angio

  2026-05-27

  This thought-leadership article explores Anlotinib hydrochloride as a next-generation multi-target tyrosine kinase inhibitor, focusing on its mechanistic innovation, translational research strategies, and the evolving landscape of angiogenesis inhibition. We integrate mechanistic insight, validated workflows, and clinical exemplars, providing actionable guidance for researchers aiming to amplify the impact and reproducibility of anti-angiogenic and cancer biology studies.

• 2X Taq PCR Master Mix (with dye): Enabling Spatial Genomics

  2026-05-27

  Explore how the 2X Taq PCR Master Mix (with dye) empowers advanced spatial sampling and pathogen transmission research in social organisms. This article uniquely details its mechanistic advantages, protocol insights, and applications in ecological genomics using a referenced ambrosia beetle protocol.

• Peroxidasin Drives GBM Progression by Regulating LDHA and Gl

  2026-05-26

  This study identifies peroxidasin (PXDN) as a critical modulator of glycolytic metabolism in glioblastoma, acting through regulation of lactate dehydrogenase A (LDHA). The findings highlight PXDN as a potential diagnostic marker and therapeutic target, offering new directions for metabolic intervention in GBM.

• Luminescent ATP Detection Assay Kit: Reliable ATP Quantifica

  2026-05-26

  This article guides biomedical researchers through common pitfalls in ATP measurement, focusing on the scientific reliability and workflow efficiency of the Luminescent ATP Detection Assay Kit (SKU K2040). By addressing real-world challenges from sample compatibility to data interpretation, it demonstrates how SKU K2040 advances energy metabolism studies and mitigates reproducibility issues across cell, tissue, and disease models.

• Outer Membrane Vesicle Display of mRNA Antigens for Tumor Va

  2026-05-25

  Li et al. have developed a rapid platform using bacteria-derived outer membrane vesicles (OMVs) engineered for surface display of mRNA antigens, enabling customizable and potent personalized tumor vaccines. This innovation addresses the limitations of lipid nanoparticles for mRNA delivery and demonstrates significant tumor suppression and immune memory in preclinical models.

• Nilotinib (AMN-107): Benchmarks for BCR-ABL and KIT Mutant I

  2026-05-25

  Nilotinib (AMN-107) is a selective tyrosine kinase inhibitor with high potency against BCR-ABL and KIT mutants, making it a key tool in chronic myeloid leukemia research. Rigorous in vitro and in vivo studies reveal nanomolar inhibition, robust antiproliferative effects, and defined solubility and storage profiles.

• Amitriptyline HCl in Lipidomics-Driven Neuropharmacology Res

  2026-05-24

  Discover how Amitriptyline HCl enables advanced studies of neurotransmitter receptor modulation and lipid metabolism in neuropharmacology research. This article uniquely explores its application in bridging neurotransmitter signaling and lipidomics, setting it apart from prior benchmarks.

• Sorafenib in Cancer Biology: Protocols, Innovations, and Pit

  2026-05-23

  Sorafenib (BAY-43-9006) is a multikinase inhibitor that enables high-impact cancer biology research by targeting Raf and VEGFR pathways. This guide details actionable protocols, advanced applications, and troubleshooting strategies, all contextualized by recent mechanistic breakthroughs and APExBIO’s high reagent standards.

• Luminescent ATP Detection Assay Kit: Unveiling Metabolic Rew

  2026-05-22

  Explore how the Luminescent ATP Detection Assay Kit enables precise cellular ATP quantification and empowers advanced metabolic research in cancer biology. This article uniquely connects assay performance with emerging insights into tumor energy metabolism.

• CBX2 Suppresses Tumor Immunogenicity via Noncanonical Comple

  2026-05-22

  The referenced study uncovers a novel mechanism by which CBX2, a polycomb group protein, dampens tumor immunogenicity and interferon signaling through a noncanonical corepressor complex with RACK1 and HDAC1. These findings provide new insight into immune evasion strategies in cancer and suggest CBX2 as a potential biomarker and therapeutic target for enhancing immunotherapy efficacy.

• Vitamin C (CAS 50-81-7): Advanced Organoid Applications in A

  2026-05-21

  Explore the advanced biomedical applications of Vitamin C (ascorbic acid) as an anticancer and antiviral agent, with a deep focus on organoid-based models and translational assay design. This article offers a unique, protocol-driven perspective on leveraging high-purity Vitamin C (CAS 50-81-7) in cutting-edge cancer and virology research.

16653 records 1/1111 page Next 12345 下5页 Last page